Sign in
Taking people in United StatesPhase 3

Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression

Key facts

Who runs it
Hospital for Special Surgery, New York
Where
New York, United StatesSee the site
Trial code
Status
Recruiting
Phase
Phase 3
People taking part
150 people, planned
Started
5 Nov 2021
Expected to end
31 Dec 2026
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Depo-Medrol 40Mg/Ml Suspension for Injection
  • Placebo
Record updated
28 April 2026

Who can take part

Age
18 years to 85 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Patients scheduled to undergo 1 to 2 level laminectomy
  • Between the ages of 18-85

Who cannot take part

  • Minimally invasive surgery
  • Prior daily opioid usage within 6 months
  • Use of concomitant procedures such as spinal fusion, revision procedure at the same level
  • History of a chronic pain syndrome, uncontrolled diabetes defined as A1C > 6.5, immunocompromised condition such as active cancer treatment, history of transplant, benign prostatic hyperplasia or history of urinary retention, and other conditions which require chronic steroid therapy or immunosuppressants
  • Patients allergic to Depo-Medrol and/or glucocorticoids, or other steroids
  • Non-English speakers

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 85 years old?

This trial is currently available in United States.

  • Hospital for Special SurgeryNew York, United StatesContact: Matthew Cunningham, MD, PhDTaking people

About the trial

What the trial wants to find out

This study seeks to evaluate the impact of intra-operative topical epidural steroid usage in patients undergoing 1-2 level lumbar laminectomy. The study will examine post-operative opioid usage, length of stay, return to work, and patient reported outcomes following these procedures.

The 2 groups in the trial

  • Group 1: Topical SteroidTreatment being tested

    Treatment: Depo-Medrol 40Mg/Ml Suspension for Injection

  • Group 2: Topical Normal SalinePlacebo, for comparison

    Treatment: Placebo

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Topical Epidural Steroid Usage in Patients Undergoing Posterior Lumbar Decompression: A Randomized Control Trial
Criteria questions
Built from NCT05058287, who can take part
Record updated
28 April 2026